Back to Search
FIROOZEH SAHEBI, MD
MD
Transplant Surgery Physician
NPI: 1538217435IndividualAccepts Medicare
Specialties, Licenses & Credentials
Transplant Surgery PhysicianPrimary
Transplant Surgery
Code: 204F00000X
A50983(CA)
Education
OTHER
Class of 1987
Research & Publications (15)
Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma.
PMID 16565743·Bone Marrow Transplant·2006
3-trial
Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD.
PMID 19503110·Bone Marrow Transplant·2010
2-rct
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
PMID 19015394·Blood·2009
3-trial
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.
PMID 18759762·Br J Haematol·2008
4-observational
Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosis.
PMID 17085309·Biol Blood Marrow Transplant·2006
3-trial
A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma.
PMID 16002426·Blood·2005
3-trial
Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease.
PMID 15812396·Biol Blood Marrow Transplant·2005
8-other
Acute renal failure after nonmyeloablative hematopoietic cell transplantation.
PMID 15213275·J Am Soc Nephrol·2004
8-other
Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies.
PMID 15064696·Bone Marrow Transplant·2004
3-trial
A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome.
PMID 14677116·Biol Blood Marrow Transplant·2003
8-other
Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed.
PMID 14569561·Biol Blood Marrow Transplant·2003
3-trial
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma.
PMID 12855572·Blood·2003
3-trial
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases.
PMID 12430851·Int J Hematol·2002
3-trial
Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial.
PMID 11533101·J Clin Oncol·2001
3-trial
Human herpesvirus 8 (KSHV) contamination of peripheral blood and autograft products from multiple myeloma patients.
PMID 10673673·Bone Marrow Transplant·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4733 W SUNSET BLVD
LOS ANGELES, CA 90027 - Phone
- (323) 783-4011
Quick Facts
- NPI
- 1538217435
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 15
Are you this provider?
Claim Your Profile